Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Bloomer

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 1, 1982
Therapeutic implications of iodine-125 cytotoxicityW D Bloomer, W H McLaughlin, S J Adelstein
Cancer Research|October 15, 1989
Correspondence re: Yasuyuki Sugiyama et al., Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibodyW H McLaughlin, M W Epperly, W D Bloomer
Molecular Endocrinology (Baltimore, Md.)|September 1, 1988
A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumorsT Garcia, S Lehrer, W D Bloomer, et al.
Journal of the National Cancer Institute|August 19, 1992
BNCT: looking for a few good moleculesR G Zamenhof, A M Kalend, W D Bloomer
The Journal of Urology|July 1, 1984
Urinary tract toxic effects of cancer therapyI D Goldberg, M B Garnick, W D Bloomer
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Dosimetric consequences of 10B(n, alpha)7Li reaction occurring at the cellular membraneA M Kalend, W D Bloomer, M W Epperly
Radiology|February 1, 1976
Mammography of the definitively irradiated breastW D Bloomer, A L Berenberg, B N Weissman
Lancet (London, England)|May 22, 1993
Taxol and radiation recall dermatitisV T Raghavan, W D Bloomer, D E Merkel
Oncology Research|September 8, 2007
Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and IIH S Rosenzweig, M V Papadopoulou, W D Bloomer
American Journal of Clinical Oncology|March 10, 2001
Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphomaM Deutsch, K Gerszten, W D Bloomer, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|November 1, 1982
Therapeutic implications of iodine-125 cytotoxicityW D Bloomer, W H McLaughlin, S J Adelstein
Cancer Research|October 15, 1989
Correspondence re: Yasuyuki Sugiyama et al., Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibodyW H McLaughlin, M W Epperly, W D Bloomer
Molecular Endocrinology (Baltimore, Md.)|September 1, 1988
A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumorsT Garcia, S Lehrer, W D Bloomer, et al.
Journal of the National Cancer Institute|August 19, 1992
BNCT: looking for a few good moleculesR G Zamenhof, A M Kalend, W D Bloomer
The Journal of Urology|July 1, 1984
Urinary tract toxic effects of cancer therapyI D Goldberg, M B Garnick, W D Bloomer
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Dosimetric consequences of 10B(n, alpha)7Li reaction occurring at the cellular membraneA M Kalend, W D Bloomer, M W Epperly
Radiology|February 1, 1976
Mammography of the definitively irradiated breastW D Bloomer, A L Berenberg, B N Weissman
Lancet (London, England)|May 22, 1993
Taxol and radiation recall dermatitisV T Raghavan, W D Bloomer, D E Merkel
Oncology Research|September 8, 2007
Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and IIH S Rosenzweig, M V Papadopoulou, W D Bloomer
American Journal of Clinical Oncology|March 10, 2001
Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphomaM Deutsch, K Gerszten, W D Bloomer, et al.
Pageof 11